TY  - GEN
AU  - de Menthon,Mathilde
AU  - Cohen,Pascal
AU  - Pagnoux,Christian
AU  - Buchler,Matthias
AU  - Sibilia,Jean
AU  - Détrée,Frédérick
AU  - Gayraud,Martine
AU  - Khellaf,Mehdi
AU  - Penalba,Christian
AU  - Legallicier,Bruno
AU  - Mouthon,Luc
AU  - Guillevin,Loïc
TI  - Infliximab or rituximab for refractory Wegener's granulomatosis: long-term follow up. A prospective randomised multicentre study on 17 patients
SN  - 0392-856X
PY  - 2011///0823
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal
KW  - adverse effects
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - Chi-Square Distribution
KW  - Drug Resistance
KW  - Drug Substitution
KW  - Female
KW  - France
KW  - Granulomatosis with Polyangiitis
KW  - diagnosis
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Infliximab
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Middle Aged
KW  - Patient Selection
KW  - Prospective Studies
KW  - Recurrence
KW  - Remission Induction
KW  - Risk Assessment
KW  - Risk Factors
KW  - Rituximab
KW  - Severity of Illness Index
KW  - Time Factors
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
ER  -